Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 125

1.
2.

The streptococcal inhibitor of complement (SIC) protects Streptococcus pyogenes from bacteriocin-like inhibitory substance (BLIS) from Streptococcus salivarius.

Minami M, Ohmori D, Tatsuno I, Isaka M, Kawamura Y, Ohta M, Hasegawa T.

FEMS Microbiol Lett. 2009 Sep;298(1):67-73. doi: 10.1111/j.1574-6968.2009.01696.x.

PMID:
19594623
[PubMed - indexed for MEDLINE]
3.

Bacteriocin-like inhibitory substance (BLIS) production by the normal flora of the nasopharynx: potential to protect against otitis media?

Walls T, Power D, Tagg J.

J Med Microbiol. 2003 Sep;52(Pt 9):829-33.

PMID:
12909662
[PubMed - indexed for MEDLINE]
Free Article
4.

Salivaricin G32, a Homolog of the Prototype Streptococcus pyogenes Nisin-Like Lantibiotic SA-FF22, Produced by the Commensal Species Streptococcus salivarius.

Wescombe PA, Dyet KH, Dierksen KP, Power DA, Jack RW, Burton JP, Inglis MA, Wescombe AL, Tagg JR.

Int J Microbiol. 2012;2012:738503. doi: 10.1155/2012/738503. Epub 2012 Apr 8.

PMID:
22567013
[PubMed]
Free PMC Article
5.

Production of the lantibiotic salivaricin A and its variants by oral streptococci and use of a specific induction assay to detect their presence in human saliva.

Wescombe PA, Upton M, Dierksen KP, Ragland NL, Sivabalan S, Wirawan RE, Inglis MA, Moore CJ, Walker GV, Chilcott CN, Jenkinson HF, Tagg JR.

Appl Environ Microbiol. 2006 Feb;72(2):1459-66.

PMID:
16461700
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Salivaricin A2 and the novel lantibiotic salivaricin B are encoded at adjacent loci on a 190-kilobase transmissible megaplasmid in the oral probiotic strain Streptococcus salivarius K12.

Hyink O, Wescombe PA, Upton M, Ragland N, Burton JP, Tagg JR.

Appl Environ Microbiol. 2007 Feb;73(4):1107-13. Epub 2006 Dec 28.

PMID:
17194838
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Salivaricin 9, a new lantibiotic produced by Streptococcus salivarius.

Wescombe PA, Upton M, Renault P, Wirawan RE, Power D, Burton JP, Chilcott CN, Tagg JR.

Microbiology. 2011 May;157(Pt 5):1290-9. doi: 10.1099/mic.0.044719-0. Epub 2011 Feb 10.

PMID:
21310787
[PubMed - indexed for MEDLINE]
Free Article
8.

Preliminary pediatric clinical evaluation of the oral probiotic Streptococcus salivarius K12 in preventing recurrent pharyngitis and/or tonsillitis caused by Streptococcus pyogenes and recurrent acute otitis media.

Di Pierro F, Donato G, Fomia F, Adami T, Careddu D, Cassandro C, Albera R.

Int J Gen Med. 2012;5:991-7. doi: 10.2147/IJGM.S38859. Epub 2012 Nov 30.

PMID:
23233809
[PubMed]
Free PMC Article
9.

Intra- and interspecies signaling between Streptococcus salivarius and Streptococcus pyogenes mediated by SalA and SalA1 lantibiotic peptides.

Upton M, Tagg JR, Wescombe P, Jenkinson HF.

J Bacteriol. 2001 Jul;183(13):3931-8.

PMID:
11395456
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

The effect of ingestion of milk supplemented with salivaricin A-producing Streptococcus salivarius on the bacteriocin-like inhibitory activity of streptococcal populations on the tongue.

Dierksen KP, Moore CJ, Inglis M, Wescombe PA, Tagg JR.

FEMS Microbiol Ecol. 2007 Mar;59(3):584-91. Epub 2006 Oct 27.

PMID:
17069620
[PubMed - indexed for MEDLINE]
11.
12.

Megaplasmids encode differing combinations of lantibiotics in Streptococcus salivarius.

Wescombe PA, Burton JP, Cadieux PA, Klesse NA, Hyink O, Heng NC, Chilcott CN, Reid G, Tagg JR.

Antonie Van Leeuwenhoek. 2006 Oct;90(3):269-80. Epub 2006 Jul 27.

PMID:
16871420
[PubMed - indexed for MEDLINE]
13.

Inhibition of propionibacterium acnes by bacteriocin-like inhibitory substances (BLIS) produced by Streptococcus salivarius.

Bowe WP, Filip JC, DiRienzo JM, Volgina A, Margolis DJ.

J Drugs Dermatol. 2006 Oct;5(9):868-70.

PMID:
17039652
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

The production of bacteriocin-like substances by the oral bacterium Streptococcus salivarius.

Dempster RP, Tagg JR.

Arch Oral Biol. 1982;27(2):151-7.

PMID:
7044350
[PubMed - indexed for MEDLINE]
15.

Clinical evaluation of the oral probiotic Streptococcus salivarius K12 in the prevention of recurrent pharyngitis and/or tonsillitis caused by Streptococcus pyogenes in adults.

Di Pierro F, Adami T, Rapacioli G, Giardini N, Streitberger C.

Expert Opin Biol Ther. 2013 Mar;13(3):339-43. doi: 10.1517/14712598.2013.758711. Epub 2013 Jan 4.

PMID:
23286823
[PubMed - indexed for MEDLINE]
16.

Synergistic effect between two bacteriocin-like inhibitory substances produced by Lactobacilli Strains with inhibitory activity for Streptococcus agalactiae.

Ruíz FO, Gerbaldo G, García MJ, Giordano W, Pascual L, Barberis IL.

Curr Microbiol. 2012 Apr;64(4):349-56. doi: 10.1007/s00284-011-0077-0. Epub 2012 Jan 10.

PMID:
22231454
[PubMed - indexed for MEDLINE]
17.

Salivaricin D, a novel intrinsically trypsin-resistant lantibiotic from Streptococcus salivarius 5M6c isolated from a healthy infant.

Birri DJ, Brede DA, Nes IF.

Appl Environ Microbiol. 2012 Jan;78(2):402-10. doi: 10.1128/AEM.06588-11. Epub 2011 Nov 18.

PMID:
22101034
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Use of Streptococcus salivarius K12 in the prevention of streptococcal and viral pharyngotonsillitis in children.

Di Pierro F, Colombo M, Zanvit A, Risso P, Rottoli AS.

Drug Healthc Patient Saf. 2014 Feb 13;6:15-20. doi: 10.2147/DHPS.S59665. eCollection 2014.

PMID:
24600248
[PubMed]
Free PMC Article
19.
20.

Isolation and characterization of the lantibiotic salivaricin A and its structural gene salA from Streptococcus salivarius 20P3.

Ross KF, Ronson CW, Tagg JR.

Appl Environ Microbiol. 1993 Jul;59(7):2014-21.

PMID:
8357242
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk